logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12582717 B1

PDFFull Text
Date of Patent:
Mar. 24, 2026

Filed:

Jul. 30, 2021

Protein based excipient for active pharmaceutical ingredients

Applicant:

Rousselot B.v., Son, NL;

Inventors:

Bjorn Vergauwen, Lokeren, BE;

Guy Van De Mooter, Pellenberg, BE;

Assignee:

Dispersome IP APS, Denmark, NL;

Attorneys:

Judith Stone-Hulslander

James Velema

Lathrop GPM LLP

Primary Examiner:

Bennett M Celsa

Assistant Examiner:

Garen undefined Gotfredson

Int. Cl.
CPC ...
A61K 47/42 (2017.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/277 (2006.01); A61K 31/343 (2006.01); A61K 31/405 (2006.01); A61K 31/4166 (2006.01); A61K 31/4184 (2006.01); A61K 31/437 (2006.01); A61K 31/4422 (2006.01); A61K 31/495 (2006.01); A61K 31/496 (2006.01); A61K 31/55 (2006.01); A61K 31/5513 (2006.01); A61K 31/635 (2006.01); A61K 47/34 (2017.01);
U.S. Cl.
CPC ...
A61K 47/42 (2013.01); A61K 9/1658 (2013.01); A61K 9/19 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/277 (2013.01); A61K 31/343 (2013.01); A61K 31/405 (2013.01); A61K 31/4166 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/4422 (2013.01); A61K 31/495 (2013.01); A61K 31/496 (2013.01); A61K 31/55 (2013.01); A61K 31/5513 (2013.01); A61K 31/635 (2013.01); A61K 47/34 (2013.01);
Abstract

Provided herein is a pharmaceutical formulation comprising a protein based excipient in combination with an active pharmaceutical ingredient (API) wherein said formulation is substantially amorphous and form a substantially homogenous mixture; and further a method for producing said pharmaceutical formulation; and said pharmaceutical formulation for use as a medicament.

Find Patent Forward Citations

Vergauwen, Bjorn. (2026). Protein based excipient for active pharmaceutical ingredients (U.S. Patent No. 12582717). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12582717

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…